Please use this identifier to cite or link to this item:
http://acervodigital.unesp.br/handle/11449/131028
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jordão, Marcelo Lopes da Silva | - |
dc.contributor.author | Hatanaka, Marcelo | - |
dc.contributor.author | Ogundele, Abayomi | - |
dc.contributor.author | Silva, Maria Rosa Bet de Moraes | - |
dc.contributor.author | Vessani, Roberto Murad | - |
dc.date.accessioned | 2015-12-07T15:30:59Z | - |
dc.date.accessioned | 2016-10-25T21:22:33Z | - |
dc.date.available | 2015-12-07T15:30:59Z | - |
dc.date.available | 2016-10-25T21:22:33Z | - |
dc.date.issued | 2014 | - |
dc.identifier | http://dx.doi.org/10.2147/OPTH.S66613 | - |
dc.identifier.citation | Clinical Ophthalmology (auckland, N.z.), v. 8, p. 1527-1534, 2014. | - |
dc.identifier.issn | 1177-5467 | - |
dc.identifier.uri | http://hdl.handle.net/11449/131028 | - |
dc.identifier.uri | http://acervodigital.unesp.br/handle/11449/131028 | - |
dc.description.abstract | To assess the intraocular pressure (IOP)-lowering effect of travoprost 0.004%/timolol 0.5% fixed-dose combination (TRAV/TIM-FC) in patients not achieving the target IOP of ≤18 mmHg while on timolol 0.5% (TIM) monotherapy. A multicenter, prospective, open-label study (NCT01336569) was conducted in patients with open-angle glaucoma or ocular hypertension. Eligible patients were receiving TIM monotherapy with a screening/baseline IOP of 19-35 mmHg in ≥1 eye. TIM was discontinued on the baseline visit day (no washout period) and TRAV/TIM-FC was initiated and administered once daily at 8 pm for 4-6 weeks. The primary efficacy variable was mean change in IOP from TIM-treated baseline to study end, measured by Goldmann applanation tonometry. Results were analyzed by analysis of variance and paired samples t-test (5% significance). A total of 49 patients were enrolled (mean age, 63 [range, 42-82] years; 55.1% White; 73.5% women), and 45 were included in the intent-to-treat (ITT) population. Mean duration of treatment with TRAV/TIM-FC was 31 days. Mean ± standard deviation IOP reduction from baseline (TIM) to the follow-up visit (TRAV/TIM-FC) was -5.0±3.6 mmHg. IOP decreased significantly (P<0.0001) from baseline (22.1±2.6 mmHg) to study end (17.1±3.9 mmHg) in the ITT population, with a mean IOP reduction of 22.3%. Most patients (n=33/45; 73.3%) achieved IOP ≤18 mmHg. Two patients experienced a total of four adverse events (AEs), including a patient who reported one serious AE (enterorrhagia) that was considered unrelated to treatment, and a patient who reported one event each of drug-related redness, pruritus, and foreign body sensation. Most patients (n=47/49; 95.9%) reported no AEs. TRAV/TIM-FC lowered IOP in patients who were not at target IOP while receiving TIM monotherapy, with most patients achieving an IOP ≤18 mmHg with TRAV/TIM-FC. TRAV/TIM-FC was well tolerated in this population. | en |
dc.format.extent | 1527-1534 | - |
dc.language.iso | eng | - |
dc.publisher | Dove Press Ltd | - |
dc.source | PubMed | - |
dc.subject | Duotrav® | en |
dc.subject | Intraocular pressure | en |
dc.subject | Primary open-angle glaucoma | en |
dc.subject | Time since diagnosis | en |
dc.title | Safety and efficacy of fixed-combination travoprost/timolol in patients with open-angle glaucoma or ocular hypertension not controlled with timolol monotherapy | en |
dc.type | outro | - |
dc.contributor.institution | Universidade de São Paulo (USP) | - |
dc.contributor.institution | Global Medical Affairs | - |
dc.contributor.institution | Universidade Estadual Paulista (UNESP) | - |
dc.contributor.institution | Serviço Social da Construção Civil do Estado de São Paulo (SECONCI-SP) | - |
dc.description.affiliation | Faculdade de Medicina de Ribeirão Preto (FMRP), Universidade de São Paulo (USP), São Paulo, SP, Brasil | - |
dc.description.affiliation | Faculdade de Medicina (FMUSP), Universidade de São Paulo, São Paulo, SP, Brasil | - |
dc.description.affiliation | Global Medical Affairs, Alcon Laboratories, Inc., Fort Worth, TX, USA | - |
dc.description.affiliation | Faculdade de Medicina de Botucatu (FMB), Universidade Estadual Paulista (UNESP), Botucatu, SP, Brasil | - |
dc.description.affiliation | Hospital Geral de Itapecerica da Serra, Serviço Social da Construção Civil do Estado de São Paulo (SECONCI-SP), Itapecerica da Serra, SP, Brasil | - |
dc.description.affiliationUnesp | Universidade Estadual Paulista, Faculdade de Medicina de Botucatu | - |
dc.identifier.doi | 10.2147/OPTH.S66613 | - |
dc.rights.accessRights | Acesso aberto | - |
dc.identifier.file | PMC4144930.pdf | - |
dc.relation.ispartof | Clinical Ophthalmology (auckland, N.z.) | - |
dc.identifier.pubmed | 25170245 | - |
dc.identifier.pmc | PMC4144930 | - |
Appears in Collections: | Artigos, TCCs, Teses e Dissertações da Unesp |
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.